PatinaInsurance
Share
Disclaimer
Patina Insurance does not sell, solicit, or negotiate insurance products. All recommendations and referrals are for informational purposes only.
06/17/2026
FDA Approves Labeling Changes for Over-the-Counter (OTC) Weight Loss Drug alli (Orlistat) to Warn of Risk of Kidney Stones and Kidney Injury
Audience: Consumer, , Health Care , , Gastroenterology, Nephrology, Endocrinology
https://www.drugs.com/fda/fda-approves-labeling-changes-over-counter-otc-weight-loss-alli-orlistat-warn-risk-kidney-stones-14814.html?hash2=5ec84a3eecae5b6377f0b7729dc8c76f&utm_source=ddc&utm_medium=email&utm_campaign=FDA+Safety+Alert++FDA+Approves+Labeling+Changes+for+Over+the+Counter++OTC++Weight+Loss+Drug+alli++Orlistat++to+Warn+of+Risk+of+Kidney+Stones+and+Kidney+Injury
Click here to claim your Sponsored Listing.
